MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$143.93
Tradestie Score
42
Market Cap
$225.13B
P/E Ratio
117.7
Revenue Growth
0.1%
Analyst Upside
+4.5%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$265.58
|
$448.07B | 31.0 | 46 | Compare |
|
ABBV
ABBVIE INC.
|
$257.12
|
$431.71B | 70.8 | 53 | Compare |
|
PG
Procter & Gamble Company
|
$145.27
|
$358.52B | 21.6 | 47 | Compare |
|
NVO
Novo-Nordisk A/S
|
$43.07
|
$262.92B | 10.9 | 38 | Compare |
|
AZN
AstraZeneca PLC
|
$160.17
|
$261.56B | 23.5 | 52 | Compare |
|
NVS
Novartis AG
|
$137.16
|
$254.99B | 20.7 | 42 | Compare |
|
VZ
Verizon Communications
|
$50.61
|
$184.80B | 12.9 | 41 | Compare |
|
AMGN
Amgen Inc
|
$377.35
|
$160.70B | 24.3 | 43 | Compare |
|
PFE
Pfizer Inc.
|
$27.72
|
$154.70B | 36.4 | 48 | Compare |
|
GILD
Gilead Sciences Inc
|
$143.72
|
$137.92B | - | 44 | Compare |
More MRK Analysis
Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry